Rupert LanzenbergerDr. Lanzenberger’s research areas include multimodal neuroimaging using PET and fMRI in both psychiatric and neurological patients in comparison to healthy controls, neuroimaging in psychopharmacology, psychoneuroendocrinology including gender medicie, cognitive neuroscience, genetic neuroimaging and experimental neuronuclear medicine. Recently, new multimodal neuroimaging approaches combining pharmacological MRI (phMRI) and PET have been developed. These methodological advancements allow for the evaluation of drug effects in the brain of healthy subjects and patients. By combining molecular and functional imaging information regarding relationship between neurochemical, structural and functional alterations in psychiatric and neurological disorders may be gleaned. Read More Read Less